Global Hereditary Angioedema Therapeutic Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Hereditary Angioedema Therapeutic market size was valued at US$ 2043.2 million in 2023. With growing demand in downstream market, the Hereditary Angioedema Therapeutic is forecast to a readjusted size of US$ 2931.1 million by 2030 with a CAGR of 5.3% during review period.
The research report highlights the growth potential of the global Hereditary Angioedema Therapeutic market. Hereditary Angioedema Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hereditary Angioedema Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hereditary Angioedema Therapeutic market.
Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Hereditary Angioedema Therapeutic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hereditary Angioedema Therapeutic market. It may include historical data, market segmentation by Type (e.g., Intravenous, Subcutaneous), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hereditary Angioedema Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hereditary Angioedema Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hereditary Angioedema Therapeutic industry. This include advancements in Hereditary Angioedema Therapeutic technology, Hereditary Angioedema Therapeutic new entrants, Hereditary Angioedema Therapeutic new investment, and other innovations that are shaping the future of Hereditary Angioedema Therapeutic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hereditary Angioedema Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Hereditary Angioedema Therapeutic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hereditary Angioedema Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hereditary Angioedema Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hereditary Angioedema Therapeutic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hereditary Angioedema Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hereditary Angioedema Therapeutic market.
Market Segmentation:
Hereditary Angioedema Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Hereditary Angioedema Therapeutic market size was valued at US$ 2043.2 million in 2023. With growing demand in downstream market, the Hereditary Angioedema Therapeutic is forecast to a readjusted size of US$ 2931.1 million by 2030 with a CAGR of 5.3% during review period.
The research report highlights the growth potential of the global Hereditary Angioedema Therapeutic market. Hereditary Angioedema Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hereditary Angioedema Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hereditary Angioedema Therapeutic market.
Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Hereditary Angioedema Therapeutic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hereditary Angioedema Therapeutic market. It may include historical data, market segmentation by Type (e.g., Intravenous, Subcutaneous), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hereditary Angioedema Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hereditary Angioedema Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hereditary Angioedema Therapeutic industry. This include advancements in Hereditary Angioedema Therapeutic technology, Hereditary Angioedema Therapeutic new entrants, Hereditary Angioedema Therapeutic new investment, and other innovations that are shaping the future of Hereditary Angioedema Therapeutic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hereditary Angioedema Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Hereditary Angioedema Therapeutic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hereditary Angioedema Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hereditary Angioedema Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hereditary Angioedema Therapeutic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hereditary Angioedema Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hereditary Angioedema Therapeutic market.
Market Segmentation:
Hereditary Angioedema Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Intravenous
- Subcutaneous
- Oral
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BioCryst Pharma
- Ionis Pharma
- Pharming Group
- CSL Limited
- Shire
- Attune Pharma
- Adverum Biotechnologies
- KalVista Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size 2019-2030
2.1.2 Hereditary Angioedema Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hereditary Angioedema Therapeutic Segment by Type
2.2.1 Intravenous
2.2.2 Subcutaneous
2.2.3 Oral
2.3 Hereditary Angioedema Therapeutic Market Size by Type
2.3.1 Hereditary Angioedema Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
2.4 Hereditary Angioedema Therapeutic Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Hereditary Angioedema Therapeutic Market Size by Application
2.5.1 Hereditary Angioedema Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
3 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Hereditary Angioedema Therapeutic Market Size Market Share by Players
3.1.1 Global Hereditary Angioedema Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Hereditary Angioedema Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA THERAPEUTIC BY REGIONS
4.1 Hereditary Angioedema Therapeutic Market Size by Regions (2019-2024)
4.2 Americas Hereditary Angioedema Therapeutic Market Size Growth (2019-2024)
4.3 APAC Hereditary Angioedema Therapeutic Market Size Growth (2019-2024)
4.4 Europe Hereditary Angioedema Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa Hereditary Angioedema Therapeutic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Hereditary Angioedema Therapeutic Market Size by Country (2019-2024)
5.2 Americas Hereditary Angioedema Therapeutic Market Size by Type (2019-2024)
5.3 Americas Hereditary Angioedema Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hereditary Angioedema Therapeutic Market Size by Region (2019-2024)
6.2 APAC Hereditary Angioedema Therapeutic Market Size by Type (2019-2024)
6.3 APAC Hereditary Angioedema Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hereditary Angioedema Therapeutic by Country (2019-2024)
7.2 Europe Hereditary Angioedema Therapeutic Market Size by Type (2019-2024)
7.3 Europe Hereditary Angioedema Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hereditary Angioedema Therapeutic by Region (2019-2024)
8.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET FORECAST
10.1 Global Hereditary Angioedema Therapeutic Forecast by Regions (2025-2030)
10.1.1 Global Hereditary Angioedema Therapeutic Forecast by Regions (2025-2030)
10.1.2 Americas Hereditary Angioedema Therapeutic Forecast
10.1.3 APAC Hereditary Angioedema Therapeutic Forecast
10.1.4 Europe Hereditary Angioedema Therapeutic Forecast
10.1.5 Middle East & Africa Hereditary Angioedema Therapeutic Forecast
10.2 Americas Hereditary Angioedema Therapeutic Forecast by Country (2025-2030)
10.2.1 United States Hereditary Angioedema Therapeutic Market Forecast
10.2.2 Canada Hereditary Angioedema Therapeutic Market Forecast
10.2.3 Mexico Hereditary Angioedema Therapeutic Market Forecast
10.2.4 Brazil Hereditary Angioedema Therapeutic Market Forecast
10.3 APAC Hereditary Angioedema Therapeutic Forecast by Region (2025-2030)
10.3.1 China Hereditary Angioedema Therapeutic Market Forecast
10.3.2 Japan Hereditary Angioedema Therapeutic Market Forecast
10.3.3 Korea Hereditary Angioedema Therapeutic Market Forecast
10.3.4 Southeast Asia Hereditary Angioedema Therapeutic Market Forecast
10.3.5 India Hereditary Angioedema Therapeutic Market Forecast
10.3.6 Australia Hereditary Angioedema Therapeutic Market Forecast
10.4 Europe Hereditary Angioedema Therapeutic Forecast by Country (2025-2030)
10.4.1 Germany Hereditary Angioedema Therapeutic Market Forecast
10.4.2 France Hereditary Angioedema Therapeutic Market Forecast
10.4.3 UK Hereditary Angioedema Therapeutic Market Forecast
10.4.4 Italy Hereditary Angioedema Therapeutic Market Forecast
10.4.5 Russia Hereditary Angioedema Therapeutic Market Forecast
10.5 Middle East & Africa Hereditary Angioedema Therapeutic Forecast by Region (2025-2030)
10.5.1 Egypt Hereditary Angioedema Therapeutic Market Forecast
10.5.2 South Africa Hereditary Angioedema Therapeutic Market Forecast
10.5.3 Israel Hereditary Angioedema Therapeutic Market Forecast
10.5.4 Turkey Hereditary Angioedema Therapeutic Market Forecast
10.5.5 GCC Countries Hereditary Angioedema Therapeutic Market Forecast
10.6 Global Hereditary Angioedema Therapeutic Forecast by Type (2025-2030)
10.7 Global Hereditary Angioedema Therapeutic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 BioCryst Pharma
11.1.1 BioCryst Pharma Company Information
11.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Offered
11.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BioCryst Pharma Main Business Overview
11.1.5 BioCryst Pharma Latest Developments
11.2 Ionis Pharma
11.2.1 Ionis Pharma Company Information
11.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Offered
11.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ionis Pharma Main Business Overview
11.2.5 Ionis Pharma Latest Developments
11.3 Pharming Group
11.3.1 Pharming Group Company Information
11.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Offered
11.3.3 Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pharming Group Main Business Overview
11.3.5 Pharming Group Latest Developments
11.4 CSL Limited
11.4.1 CSL Limited Company Information
11.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Offered
11.4.3 CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CSL Limited Main Business Overview
11.4.5 CSL Limited Latest Developments
11.5 Shire
11.5.1 Shire Company Information
11.5.2 Shire Hereditary Angioedema Therapeutic Product Offered
11.5.3 Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Shire Main Business Overview
11.5.5 Shire Latest Developments
11.6 Attune Pharma
11.6.1 Attune Pharma Company Information
11.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Offered
11.6.3 Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Attune Pharma Main Business Overview
11.6.5 Attune Pharma Latest Developments
11.7 Adverum Biotechnologies
11.7.1 Adverum Biotechnologies Company Information
11.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Offered
11.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Adverum Biotechnologies Main Business Overview
11.7.5 Adverum Biotechnologies Latest Developments
11.8 KalVista Pharma
11.8.1 KalVista Pharma Company Information
11.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Offered
11.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 KalVista Pharma Main Business Overview
11.8.5 KalVista Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size 2019-2030
2.1.2 Hereditary Angioedema Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hereditary Angioedema Therapeutic Segment by Type
2.2.1 Intravenous
2.2.2 Subcutaneous
2.2.3 Oral
2.3 Hereditary Angioedema Therapeutic Market Size by Type
2.3.1 Hereditary Angioedema Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
2.4 Hereditary Angioedema Therapeutic Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Hereditary Angioedema Therapeutic Market Size by Application
2.5.1 Hereditary Angioedema Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
3 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Hereditary Angioedema Therapeutic Market Size Market Share by Players
3.1.1 Global Hereditary Angioedema Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Hereditary Angioedema Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA THERAPEUTIC BY REGIONS
4.1 Hereditary Angioedema Therapeutic Market Size by Regions (2019-2024)
4.2 Americas Hereditary Angioedema Therapeutic Market Size Growth (2019-2024)
4.3 APAC Hereditary Angioedema Therapeutic Market Size Growth (2019-2024)
4.4 Europe Hereditary Angioedema Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa Hereditary Angioedema Therapeutic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Hereditary Angioedema Therapeutic Market Size by Country (2019-2024)
5.2 Americas Hereditary Angioedema Therapeutic Market Size by Type (2019-2024)
5.3 Americas Hereditary Angioedema Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hereditary Angioedema Therapeutic Market Size by Region (2019-2024)
6.2 APAC Hereditary Angioedema Therapeutic Market Size by Type (2019-2024)
6.3 APAC Hereditary Angioedema Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hereditary Angioedema Therapeutic by Country (2019-2024)
7.2 Europe Hereditary Angioedema Therapeutic Market Size by Type (2019-2024)
7.3 Europe Hereditary Angioedema Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hereditary Angioedema Therapeutic by Region (2019-2024)
8.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET FORECAST
10.1 Global Hereditary Angioedema Therapeutic Forecast by Regions (2025-2030)
10.1.1 Global Hereditary Angioedema Therapeutic Forecast by Regions (2025-2030)
10.1.2 Americas Hereditary Angioedema Therapeutic Forecast
10.1.3 APAC Hereditary Angioedema Therapeutic Forecast
10.1.4 Europe Hereditary Angioedema Therapeutic Forecast
10.1.5 Middle East & Africa Hereditary Angioedema Therapeutic Forecast
10.2 Americas Hereditary Angioedema Therapeutic Forecast by Country (2025-2030)
10.2.1 United States Hereditary Angioedema Therapeutic Market Forecast
10.2.2 Canada Hereditary Angioedema Therapeutic Market Forecast
10.2.3 Mexico Hereditary Angioedema Therapeutic Market Forecast
10.2.4 Brazil Hereditary Angioedema Therapeutic Market Forecast
10.3 APAC Hereditary Angioedema Therapeutic Forecast by Region (2025-2030)
10.3.1 China Hereditary Angioedema Therapeutic Market Forecast
10.3.2 Japan Hereditary Angioedema Therapeutic Market Forecast
10.3.3 Korea Hereditary Angioedema Therapeutic Market Forecast
10.3.4 Southeast Asia Hereditary Angioedema Therapeutic Market Forecast
10.3.5 India Hereditary Angioedema Therapeutic Market Forecast
10.3.6 Australia Hereditary Angioedema Therapeutic Market Forecast
10.4 Europe Hereditary Angioedema Therapeutic Forecast by Country (2025-2030)
10.4.1 Germany Hereditary Angioedema Therapeutic Market Forecast
10.4.2 France Hereditary Angioedema Therapeutic Market Forecast
10.4.3 UK Hereditary Angioedema Therapeutic Market Forecast
10.4.4 Italy Hereditary Angioedema Therapeutic Market Forecast
10.4.5 Russia Hereditary Angioedema Therapeutic Market Forecast
10.5 Middle East & Africa Hereditary Angioedema Therapeutic Forecast by Region (2025-2030)
10.5.1 Egypt Hereditary Angioedema Therapeutic Market Forecast
10.5.2 South Africa Hereditary Angioedema Therapeutic Market Forecast
10.5.3 Israel Hereditary Angioedema Therapeutic Market Forecast
10.5.4 Turkey Hereditary Angioedema Therapeutic Market Forecast
10.5.5 GCC Countries Hereditary Angioedema Therapeutic Market Forecast
10.6 Global Hereditary Angioedema Therapeutic Forecast by Type (2025-2030)
10.7 Global Hereditary Angioedema Therapeutic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 BioCryst Pharma
11.1.1 BioCryst Pharma Company Information
11.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Offered
11.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BioCryst Pharma Main Business Overview
11.1.5 BioCryst Pharma Latest Developments
11.2 Ionis Pharma
11.2.1 Ionis Pharma Company Information
11.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Offered
11.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ionis Pharma Main Business Overview
11.2.5 Ionis Pharma Latest Developments
11.3 Pharming Group
11.3.1 Pharming Group Company Information
11.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Offered
11.3.3 Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pharming Group Main Business Overview
11.3.5 Pharming Group Latest Developments
11.4 CSL Limited
11.4.1 CSL Limited Company Information
11.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Offered
11.4.3 CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CSL Limited Main Business Overview
11.4.5 CSL Limited Latest Developments
11.5 Shire
11.5.1 Shire Company Information
11.5.2 Shire Hereditary Angioedema Therapeutic Product Offered
11.5.3 Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Shire Main Business Overview
11.5.5 Shire Latest Developments
11.6 Attune Pharma
11.6.1 Attune Pharma Company Information
11.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Offered
11.6.3 Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Attune Pharma Main Business Overview
11.6.5 Attune Pharma Latest Developments
11.7 Adverum Biotechnologies
11.7.1 Adverum Biotechnologies Company Information
11.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Offered
11.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Adverum Biotechnologies Main Business Overview
11.7.5 Adverum Biotechnologies Latest Developments
11.8 KalVista Pharma
11.8.1 KalVista Pharma Company Information
11.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Offered
11.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 KalVista Pharma Main Business Overview
11.8.5 KalVista Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hereditary Angioedema Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Intravenous
Table 3. Major Players of Subcutaneous
Table 4. Major Players of Oral
Table 5. Hereditary Angioedema Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 8. Hereditary Angioedema Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 11. Global Hereditary Angioedema Therapeutic Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Hereditary Angioedema Therapeutic Revenue Market Share by Player (2019-2024)
Table 13. Hereditary Angioedema Therapeutic Key Players Head office and Products Offered
Table 14. Hereditary Angioedema Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hereditary Angioedema Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Hereditary Angioedema Therapeutic Market Size Market Share by Regions (2019-2024)
Table 19. Global Hereditary Angioedema Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Hereditary Angioedema Therapeutic Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Hereditary Angioedema Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Country (2019-2024)
Table 23. Americas Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 25. Americas Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 27. APAC Hereditary Angioedema Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Region (2019-2024)
Table 29. APAC Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 31. APAC Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 33. Europe Hereditary Angioedema Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Country (2019-2024)
Table 35. Europe Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 37. Europe Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Hereditary Angioedema Therapeutic
Table 46. Key Market Challenges & Risks of Hereditary Angioedema Therapeutic
Table 47. Key Industry Trends of Hereditary Angioedema Therapeutic
Table 48. Global Hereditary Angioedema Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Hereditary Angioedema Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. BioCryst Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 53. BioCryst Pharma Hereditary Angioedema Therapeutic Product Offered
Table 54. BioCryst Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. BioCryst Pharma Main Business
Table 56. BioCryst Pharma Latest Developments
Table 57. Ionis Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 58. Ionis Pharma Hereditary Angioedema Therapeutic Product Offered
Table 59. Ionis Pharma Main Business
Table 60. Ionis Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Ionis Pharma Latest Developments
Table 62. Pharming Group Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 63. Pharming Group Hereditary Angioedema Therapeutic Product Offered
Table 64. Pharming Group Main Business
Table 65. Pharming Group Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Pharming Group Latest Developments
Table 67. CSL Limited Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 68. CSL Limited Hereditary Angioedema Therapeutic Product Offered
Table 69. CSL Limited Main Business
Table 70. CSL Limited Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. CSL Limited Latest Developments
Table 72. Shire Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 73. Shire Hereditary Angioedema Therapeutic Product Offered
Table 74. Shire Main Business
Table 75. Shire Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Shire Latest Developments
Table 77. Attune Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 78. Attune Pharma Hereditary Angioedema Therapeutic Product Offered
Table 79. Attune Pharma Main Business
Table 80. Attune Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Attune Pharma Latest Developments
Table 82. Adverum Biotechnologies Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 83. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Offered
Table 84. Adverum Biotechnologies Main Business
Table 85. Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Adverum Biotechnologies Latest Developments
Table 87. KalVista Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 88. KalVista Pharma Hereditary Angioedema Therapeutic Product Offered
Table 89. KalVista Pharma Main Business
Table 90. KalVista Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. KalVista Pharma Latest Developments
Table 1. Hereditary Angioedema Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Intravenous
Table 3. Major Players of Subcutaneous
Table 4. Major Players of Oral
Table 5. Hereditary Angioedema Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 8. Hereditary Angioedema Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 11. Global Hereditary Angioedema Therapeutic Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Hereditary Angioedema Therapeutic Revenue Market Share by Player (2019-2024)
Table 13. Hereditary Angioedema Therapeutic Key Players Head office and Products Offered
Table 14. Hereditary Angioedema Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hereditary Angioedema Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Hereditary Angioedema Therapeutic Market Size Market Share by Regions (2019-2024)
Table 19. Global Hereditary Angioedema Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Hereditary Angioedema Therapeutic Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Hereditary Angioedema Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Country (2019-2024)
Table 23. Americas Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 25. Americas Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 27. APAC Hereditary Angioedema Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Region (2019-2024)
Table 29. APAC Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 31. APAC Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 33. Europe Hereditary Angioedema Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Country (2019-2024)
Table 35. Europe Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 37. Europe Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Hereditary Angioedema Therapeutic
Table 46. Key Market Challenges & Risks of Hereditary Angioedema Therapeutic
Table 47. Key Industry Trends of Hereditary Angioedema Therapeutic
Table 48. Global Hereditary Angioedema Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Hereditary Angioedema Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. BioCryst Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 53. BioCryst Pharma Hereditary Angioedema Therapeutic Product Offered
Table 54. BioCryst Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. BioCryst Pharma Main Business
Table 56. BioCryst Pharma Latest Developments
Table 57. Ionis Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 58. Ionis Pharma Hereditary Angioedema Therapeutic Product Offered
Table 59. Ionis Pharma Main Business
Table 60. Ionis Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Ionis Pharma Latest Developments
Table 62. Pharming Group Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 63. Pharming Group Hereditary Angioedema Therapeutic Product Offered
Table 64. Pharming Group Main Business
Table 65. Pharming Group Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Pharming Group Latest Developments
Table 67. CSL Limited Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 68. CSL Limited Hereditary Angioedema Therapeutic Product Offered
Table 69. CSL Limited Main Business
Table 70. CSL Limited Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. CSL Limited Latest Developments
Table 72. Shire Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 73. Shire Hereditary Angioedema Therapeutic Product Offered
Table 74. Shire Main Business
Table 75. Shire Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Shire Latest Developments
Table 77. Attune Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 78. Attune Pharma Hereditary Angioedema Therapeutic Product Offered
Table 79. Attune Pharma Main Business
Table 80. Attune Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Attune Pharma Latest Developments
Table 82. Adverum Biotechnologies Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 83. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Offered
Table 84. Adverum Biotechnologies Main Business
Table 85. Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Adverum Biotechnologies Latest Developments
Table 87. KalVista Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 88. KalVista Pharma Hereditary Angioedema Therapeutic Product Offered
Table 89. KalVista Pharma Main Business
Table 90. KalVista Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. KalVista Pharma Latest Developments
LIST OF FIGURES
Figure 1. Hereditary Angioedema Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hereditary Angioedema Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Hereditary Angioedema Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Hereditary Angioedema Therapeutic Sales Market Share by Country/Region (2023)
Figure 8. Hereditary Angioedema Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Hereditary Angioedema Therapeutic Market Size Market Share by Type in 2023
Figure 10. Hereditary Angioedema Therapeutic in Hospitals
Figure 11. Global Hereditary Angioedema Therapeutic Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Hereditary Angioedema Therapeutic in Clinics
Figure 13. Global Hereditary Angioedema Therapeutic Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Hereditary Angioedema Therapeutic in Others
Figure 15. Global Hereditary Angioedema Therapeutic Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2023
Figure 17. Global Hereditary Angioedema Therapeutic Revenue Market Share by Player in 2023
Figure 18. Global Hereditary Angioedema Therapeutic Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Hereditary Angioedema Therapeutic Market Size 2019-2024 ($ Millions)
Figure 20. APAC Hereditary Angioedema Therapeutic Market Size 2019-2024 ($ Millions)
Figure 21. Europe Hereditary Angioedema Therapeutic Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Hereditary Angioedema Therapeutic Market Size 2019-2024 ($ Millions)
Figure 23. Americas Hereditary Angioedema Therapeutic Value Market Share by Country in 2023
Figure 24. United States Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Region in 2023
Figure 29. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Type in 2023
Figure 30. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2023
Figure 31. China Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Country in 2023
Figure 38. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Figure 39. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Figure 40. Germany Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 54. APAC Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 55. Europe Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 57. United States Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 58. Canada Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 61. China Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 62. Japan Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 63. Korea Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 65. India Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 66. Australia Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 67. Germany Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 68. France Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 69. UK Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 70. Italy Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 71. Russia Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 72. Spain Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 75. Israel Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 78. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Hereditary Angioedema Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hereditary Angioedema Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Hereditary Angioedema Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Hereditary Angioedema Therapeutic Sales Market Share by Country/Region (2023)
Figure 8. Hereditary Angioedema Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Hereditary Angioedema Therapeutic Market Size Market Share by Type in 2023
Figure 10. Hereditary Angioedema Therapeutic in Hospitals
Figure 11. Global Hereditary Angioedema Therapeutic Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Hereditary Angioedema Therapeutic in Clinics
Figure 13. Global Hereditary Angioedema Therapeutic Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Hereditary Angioedema Therapeutic in Others
Figure 15. Global Hereditary Angioedema Therapeutic Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2023
Figure 17. Global Hereditary Angioedema Therapeutic Revenue Market Share by Player in 2023
Figure 18. Global Hereditary Angioedema Therapeutic Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Hereditary Angioedema Therapeutic Market Size 2019-2024 ($ Millions)
Figure 20. APAC Hereditary Angioedema Therapeutic Market Size 2019-2024 ($ Millions)
Figure 21. Europe Hereditary Angioedema Therapeutic Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Hereditary Angioedema Therapeutic Market Size 2019-2024 ($ Millions)
Figure 23. Americas Hereditary Angioedema Therapeutic Value Market Share by Country in 2023
Figure 24. United States Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Region in 2023
Figure 29. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Type in 2023
Figure 30. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2023
Figure 31. China Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Country in 2023
Figure 38. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Figure 39. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Figure 40. Germany Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Hereditary Angioedema Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 54. APAC Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 55. Europe Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 57. United States Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 58. Canada Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 61. China Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 62. Japan Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 63. Korea Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 65. India Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 66. Australia Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 67. Germany Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 68. France Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 69. UK Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 70. Italy Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 71. Russia Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 72. Spain Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 75. Israel Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Hereditary Angioedema Therapeutic Market Size 2025-2030 ($ Millions)
Figure 78. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Application (2025-2030)
